Glioblastoma (GBM) is the most malignant type of primary intracranial tumor with a median overall survival only 14 months, very poor prognosis and recurrence rate 90%. It difficult to reflect complex structure function GBM microenvironment in vivo using traditional vitro models. GBM-on-a-chip platforms can integrate biological or chemical functional units into chip, mimicking functions cells. T...